Shilpa Medicare Jadcherla facility clears TGA, Australia GMP inspection

Published On 2023-10-18 09:00 GMT   |   Update On 2023-10-18 09:01 GMT
Advertisement

KarnatakaShilpa Medicare has recently informed through a BSE filing that the Company’s finished dosage form manufacturing facility, Unit IV, situated at Pharma SEZ, Jadcherla, Telangana state has successfully closed-out a GMP Inspection from TGA, Australia, as per communication received on 17 th October 2023.

The facility is involved in the manufacturing, packaging, labelling, testing and release of finished dosage forms (sterile injections and non-sterile oral solids) for the treatment of various forms of cancer and adjuvant therapy.

Advertisement

This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years. The successful closure of this inspection will allow the company to register and market its products in Australia and other rest of world markets which recognize Australian GMP.

"The company remains committed to maintain the GMP status and quality standards as per the expectations and standards of Global Regulatory Authorities," Shilpa Medicare said.

Read also: Shilpa Medicare gets Health Canada GMP approval for Jadcherla facility

Shilpa Medicare Limited started its operations as an API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of API and Formulation globally in different regulated markets.

Read also: Shilpa Pharma Lifesciences Unit II Raichur facility clears PMDA Japan GMP inspection




Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News